Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-03

Clinical Trial Update: Effectiveness and Safety Comparison of Lunaphil Ultra (Hyaluronic Acid, by Espad Pharmed Co.) Versus Juvederm Ultra 4® (Hyaluronic Acid, by Allergan Co.) in Nasolabial Folds (NLFs) Management [NA]

View source ↗

Summary

A completed clinical trial comparing Lunaphil Ultra to Juvederm Ultra 4 for managing moderate to severe nasolabial folds, reporting effectiveness and safety res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Juvederm Ultra 4 (Hyaluronic acid)
  • Lunaphil Ultra (Hyaluronic acid)

Snippet

Sponsor: Espad Pharmed | Conditions: Moderate or Severe Nasolabial Folds | NA | Status: COMPLETED | Results posted: 2026-02-03